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ABSTRACT
The described clinical case presents 39-year-old patient with no clinically significant accompanying dis-
eases. Since the beginning of October 2015, the patient has complained of fever, abdominal pain and gener-
alized enlarged lymph nodes. Biopsy of axillary lymph node evidences Rosai-Dorfman-Destombes (RDD) 
disease. Treatment with corticosteroids has been started but with no clear influence on paraclinical activ-
ity and lymphadenomegaly. From the additionally made examinations, clinical laboratory data for malig-
nant histiocytosis are found. According to literary data, in 27% of patients suffering from RDD, it trans-
forms into malignant histiocytosis. The presented clinical case is interesting not only because of the regis-
tered clinical laboratory data of malignant histiocytosis but for the unclear diagnostic and prognostic im-
portance of this phenomenon, as well.
Keywords: Rosai-Dorfman-Destombes disease, sinus histiocytosis with massive lymphadenomegaly, ma-
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INTRODUCTION 
Rosai-Dorfman–Destombes (RDD) disease, 
known as sinus histiocytosis with massive lymph-
adenomegaly, was described for the first time by 
Destombes in 1969 (1). In the same year, Juan Rosai 
and Ronald Dorfman found another 4 cases of the 
disease, and later – in 1972, they analyzed another 
30 reports and defined it as a nosological entity (2). 
RDD is a benign, systematic, histioproliferative dis-
ease with unknown etiology. It most often presents 
with massive lymphadenomegaly, fever, and extra-
nodal manifestations. The size of the affected lymph 
nodes varies – from massive and compressing to dis-
creet lymphadenomegaly. In 87% of the cases, nod-
al involvement was found, and in 20 to 40% – extra-
nodal localization (skin, soft tissues, central nervous 
system, etc.) (3-9). 
Emperipolesis and positive immunohistochem-
ical markers for histiocytes (S100 and CD68) in com-
bination with negative CD1 are typical and sufficient 
for accurate diagnosis to be made (2,8,10).
RDD occurs extremely rarely. The calculated 
frequency in USA is about 100 cases a year (11).
The etiology of the disease is unknown and 
histiocytosis is still considered idiopathic. Some re-
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Hematological investigations showed mild-
grade anemia (Hb 116 g/L),  leukocytosis (Leu-
11.53x109/L) and normal platelet count. The chemis-
try panel had no deviations. Tuberculin test and se-
rological tests for viral infections including HbsAg 
/-/, Anti-HCV /-/, Anti-HIV/-/, Anti HSV IgM /-/, 
Anti HSV IgMG /-/, Anti HSV2 IgM /-/, Anti HSV2 
/-/, Anti CMV IgG /-/, Anti CMV IgM /-/, Anti EBV 
IgM /-/ were negative.
From the computed tomography of the tho-
rax and abdomen, cervical, axillary, abdominal 
lymphadenopathy and hepatosplenomegaly were 
established.
Biopsy performed on axillary lymph node with 
subsequent histological and immunohistochemical 
examination evidenced a morphological image of si-
nus histiocytosis. Fig.1 presents a histological prep-
aration from a lymph node with damaged architec-
tonics, massive sinusoidal dilation with presence of 
histiocytes, lymphocytes and plasma cells (10).  Em-
peripolesis in the cytoplasm of histiocytes is a classi-
cal and pathognomonic finding (2,9,12).
Immunohistochemical examination of his-
tiocytes in sinus histiocytosis with massive lymph-
adenomegaly /SHML/ shows positive marking for 
CD68, S100, CD163, Ki67 and usually negative for 
CD1a (Fig. 2).
Approximately 2 weeks after diagnosis was 
made, with a treatment with corticosteroids per-
formed, clinical laboratory examinations showed ex-
searchers of the disease connect it to an infectious 
agent. However, the current results are contradicto-
ry. Some publications show that viral infections such 
as Human Herpesvirus 6 (HHV-6), Parvovirus B19, 
Epstein-Barr virus can be a trigger factor in the etio-
pathogenesis (9, 12-14). An expression of the HHV-
6 antigen is identified in histiocytes in patients with 
RDD, while parvovirus B19 is found in lymphocytes, 
phagocytized by histiocytes (14,15). The disease is 
most often found in children and adolescents, with 
morbidity peak about the age of 20. There is no con-
vincing evidence of racial, ethnic or socio-economic 
predisposition. 
In the literature, there is no consent with respect 
to the treatment protocol. With most patients, watch-
and-wait approach is applied. Progressive disease or 
cases with symptoms are treated with high-dose ste-
roids, surgically, radiotherapy treatment and/or che-
motherapy in refractory cases (16). Data from apply-
ing high-dose interferon alfa show achieving long-
lasting remission (17). Disease development can be 
feeble, last for years and conclude with spontaneous 
regression (18).If there is progression, the prognosis 
is bad. A few cases of progressive development are 
described, including 17 cases with lethal outcome. 
Differential diagnosis in RDD is difficult and 
includes tuberculosis, sarcoidosis, Wegener’s gran-
ulomatosis, Gaucher disease, hemophagocytic lym-
phohistiocytosis, juvenile xanthogranuloma. From 
the group of malignant diseases, in terms of differ-
ential diagnosis, the following should be taken into 
account:  acute lymphoblastic leukaemia, Hodgkin 
disease and Non-Hodgkin lymphoma, metastases 
from melanoma, carcinoma and histiocytic sarcoma 
(18-20). 
CLINICAL CASE
We present a 39-year-old male, with no clini-
cally significant pre-existing conditions. At the be-
ginning of October 2015 he presented with fever up 
to 39 °C, significant abdominal pain and general-
ized enlarged unpainful lymph nodes. Long-term, 
outpatient, antibiotic treatment was performed with 
no significant effect. Physical examination of the pa-
tient revealed fever and generalized enlarged lymph 
nodes (cervical, axillary and inguinal lymphadenop-
athy) with size 3/3 cm, moderate hepatomegaly and 
splenomegaly. 
Fig. 1. Histological preparation from lymph node with 
damaged architectonics, massive sinusoidal dilation with 
presence of histiocytes, lymphocytes and plasma cells 
-lymphophagocytosis and emperipolesis
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acerbation: deepening of the anemic syndrome (Hb-
78x109/l), increasing leukocytosis (Leu-46.52x109/l) 
and occurrence of thrombocytopenia (Plt-85x109/l). 
They persisted, with apparent tendency of exacer-
bation of the febrile-intoxication syndrome, gener-
alized lymphadenomegaly and hepatosplenomega-
ly. Ascites, hypoalbuminemia and peripheral edema 
became present. The patient’s state was deteriorating 
progressively. An increased percentage of monocyte 
population was determined in the peripheral blood 
and bone marrow (Fig. 3 and Fig. 4). 
Based on clinical laboratory data, it was sug-
gested the transformation of disease into malig-
nant histiocytosis should be considered. Treatment 
was performed according to a protocol R-CHOP but 
there was no therapeutic response. A few days later, a 
fatal outcome was registered for the patient.
DISCUSSION 
RDD is a benign disease of histiocytes, which 
represents real challenge in regard to clinical and 
pathological diagnosis. In the case described, unde-
niable evidence is present for the presence of classi-
cal, clinical, morphological and immunohistochem-
ical image of sinus histiocytosis. Usually, histiocytes 
in RDD differ morphologically from those in Lang-
erhans cell histiocytosis or in interdigitating dendrit-
ic cells. Immunohistochemical examination is suf-
ficient in order to differentiate morphologically dif-
ficult cases. Unlike Langerhans cell histiocytosis, 
where mutation BRAFV600E can be found, in RDD 
– this mutation is not present (21, 22). This fact can be 
used for a differentiation of both diseases in extreme-
ly rare cases where the morphological and immuno-
histochemical examinations are uncertain.
Fig. 2. Immunohistochemical markers – CD68/+/, S100/+/
Fig. 3. Photomicrograph showing a high proportion of 
monocyte in peripheral blood smear (The monocyte has a 
pale, greyish-blue vacuolated cytoplasm)
Fig. 4. Bone marrow examination (bone marrow aspira-
tion). The bone marrow is hypercellular and shows my-
eloid preponderance and left shift with increased number 
of immature monocytic precursors
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In the literature, there are single cases describ-
ing the progressive development or transformation 
of RDD into a malignant process. Prognostic sig-
nificance of this phenomenon is of particular im-
portance and calls for adopting an individual ap-
proach for therapeutic behavior with the patient. Ac-
cording to literary data, the following forms of trans-
formation can be discussed: 1) in about 27% of the 
cases, RDD can transform into a malignant process 
(Non-Hodgkin lymphoma, acute lymphoblastic leu-
kemia); 2) histological changes such as SHML (sinus 
histiocytosis with massive lymphadenomegaly) are 
found in the lymph nodes of patients with autoim-
mune lymphoproliferative syndrome (ALPS), most 
often connected with mutations in the gene, which 
codes the TNFRSF6 Fas antigen. This shows that 1/3 
of the cases of SHML are connected with disruption 
of apoptosis (18, 23).
The case reported by us confirms the data spec-
ified above. This reminds us that the differential di-
agnosis of hematological diseases, depending on 
clinical manifestation, can include many different 
possibilities irrespective of the patient‘s age. 
CONCLUSION
Sinus histiocytosis with massive lymphadeno-
megaly, also known as Rosai-Dorfman-Destombes 
disease, usually surprises clinicians. It is interesting 
due to its rare occurrence in clinical practice, absence 
of pathognomonic symptoms and unclear evolution.
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